Posted on 04/05/2021 11:57:31 AM PDT by SeekAndFind
Johnson & Johnson (NYSE: JNJ) began the rollout of its single-dose Covid-19 shot in the U.S. in early March. Here are some of the recent developments relating to the vaccine.
While Johnson & Johnson beat its March delivery target for the U.S., providing the government with over 20 million doses, a recent error at the plant of a vaccine manufacturing partner, Emergent BioSolutions, apparently contaminated about 15 million doses of the shot. The problem was identified quickly, and none of the doses left the plant. While we think it is likely that the error could impact near-term supply growth for the shot, J&J says that it is on track to deliver 100 million doses to the U.S. by the end of June, or possibly sooner.
Separately, the vaccine received approval from E.U regulators in mid-March and Johnson & Johnson says that it is likely to start delivering doses to the bloc starting from April 19. The E.U has entered into a firm order for 200 million doses of the vaccine, and has an option for 200 million additional doses. The E.U’s vaccination drive has been progressing much slower than expected, and it is likely that the J&J shot will help to speed up inoculation efforts considerably.
Thus far, less than 4% of the global population ((Bloomberg vaccine tracker)) has been vaccinated for Covid-19 and we think that J&J’s shot could play a big role in improving coverage. The shot’s single dose requirement and the fact that it can be stored at standard refrigerator temperatures of 2 to 8 degrees Celsius should make it much more accessible. J&J plans to produce around one billion doses this year.
(Excerpt) Read more at forbes.com ...
The idea being that...as with Covid itself... people with co-morbidities (like propensity for blood clots etc...) may also be vulnerable to adverse response to certain vaccines. And this needs to be studied more.
Also there is another thread on FR about those who have had Covid recently or already have it but are unaware. They should ideally be screened before getting vaccine. It’s better to wait.
Got the J&J shot last week. Family felt sicker than dog. No effect on me whatsoever.
“Got mine this morning.”
I heard that this one, thankfully, doesn’t make you grow horns like the 2-shot ‘vaccines’, all you get is toenails out of your elbows. Any sign of that happening to you yet, or perhaps it will be a few days?
These numbers available from the CDC web site:
through late March 2021, US only.
Moderna vaccine: 1016 dead
Pfizer vaccine: 946 dead
J&J vaccine: 16 dead
Unknown Mfg: 7 dead
Total 1,985 dead
That’s just in reports filed with the CDC.
I will go to the website and look, but I am wondering if the fact that J&J being so low is because the number of doses administered are lower since it was the most recently approved and just one dose required...
Seems like percentage of total doses would be more enlightening.
Son and I both got it yesterday. I’m fine and he’s sick with flu like symptoms.
I’ve been getting regular screenings for COVID-19 due to work issues (everyone in a client’s office came down with it in a time period where I’d spent time in the office and could have been infected and another client that said she’d had it and was safe to be around - who turned out to either *not* have had it when she thought or got reinfected. Fun!) Not an issue in my case.
Dunno - I’m waiting for the mutant superpowers that let me take over the world. :P
“Dunno - I’m waiting for the mutant superpowers that let me take over the world.”
So you’re LUCKY, so far. I’ll check back with you in a few days to get a read on your elbows.
Yes I’m wondering if screening for Covid and prior Covid should be a requirement...before the shot.
Just curious why J&J didn’t develop their vaccine for Coronavirus 30 years ago than?
Because COVID-19 didn’t exist then, and this tech was originally supposed to be used for ‘gene therapy’ - which it failed at. Genetic changes were not able to be effected by this means. However, the tech had some success in treating other diseases and prior to COVID-19, it produced the first working and approved Ebola vaccine.
I know for a fact that those who have been diagnosed and confirmed with COVID-19 in the DFW area have been advised to wait at least six weeks before getting a vaccine - normally you wouldn’t need a vaccine for a viral disease you recovered from, but there are documented cases here in Dallas of reinfection or resurgence after recovery.
Wife got the J&J appx 2 weeks ago. She felt rotten for about 1.5 days and still has a little discomfort in the injected arm. In the process she learned that women are to refrain from mammograms for several weeks following any of these vaccines, as they can enlarge lymph nodes and show false positives on a mammogram.
It’s being sabotaged by the other pharma giants with the help of the MSM?
Had the first Moderna a couple weeks ago. Unless I pressed on the spot, I couldn’t tell I had it. Tetanus and Shingrix were way worse.
I hear the second shot gas more effects the day after. I guess the more shots, the worse you feel the next day. Just like Jack Daniels.
*
Exactly why I held out for the J&J vaccine. I don’t know if it’s considered a “co-morbidity”, but I have epilepsy and am already on two medications for that (after years of trial and error) - so didn’t want to be more experimental than I had to be with a vaccine.
Find out where you can sign up for the vaccination and specify the J&J. You will be on a list.
When they get it in they will contact you.
I had my second Moderna shot Friday. Both arms hurt, no sleep Friday night, splitter Friday and Saturday, some shortness of breath Saturday. Much better yesterday and today. sleep, water and motion seem to be the cure. (but Tylenol helps.)
Which vaccines use the traditional (dead/deactivated virus) approach to vaccines (not the mRna)?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.